Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment
Spotlight on our joint effort with Servier to advance the discovery and simulation of drugs for Pancreatic Cancer. This strategic partnership aims to delve into the intricate mechanisms of this complex disease, with the goal of expediting the development of innovative therapies for individuals affected by pancreatic cancer. Read what Servier had to say about […]
Aitia and Pancreatic Cancer Action Network Partner to Transform De-Identified Multi-Omic Patient Data into Digital Twins to Drive New Discoveries and Improve Patient Outcomes
LOS ANGELES and SOMERVILLE, MA, Sept 27, 2023: Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs, today announced a collaboration with the Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer. This strategic collaboration marks a significant milestone for Aitia, […]
Driving Research in Pancreatic Cancer: Join our CEO, Colin Hill on the PanCAN Scientific Summit 2023
We are thrilled to announce that Aitia will be participating in the highly anticipated PanCAN Scientific Summit 2023 conference. Our CEO, Colin Hill, will be taking the stage in the scientific session to talk about Aitia’s commitment in accelerating AI-driven discoveries in pancreatic cancer and share valuable insights on harnessing AI technology and Digital Twins […]
Servier and Aitia Mobilize AI and Digital Twins to Treat Pancreatic Cancer
The French pharmaceutical group Servier and Aitia announced on May 17th a multi-year partnership agreement for the discovery and simulation of drugs in pancreatic cancer. It is based on the combination of Servier’s expertise in preclinical trials with Aitia’s technology, which is based on artificial intelligence and Gemini Digital Twins. Read more on the latest […]
World Congress: AI and Digital Twins to Drive the Next Generation Drug Discovery and Development
Watch Colin Hill’s talk at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session focused on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation was followed by a fireside chat with Julie Frearson, Chief Scientific Officer at Charles River Laboratories. This […]
Servier Doubles Up on Digital Twin Alliance with Aitia
The new project will focus on pancreatic cancer, and builds on a collaboration in the blood cancer multiple myeloma that was started by the two companies last year. Read more on the latest collaboration between Servier and Aitia, in Pharmaphorum article. Full article here. Picture Credit: Pharmaphorum